Healthcare

As the year draws to a close, UnitedHealth Group faces a confluence of high-stakes operational and regulatory challenges. The outcomes...

The German biotech firm BioNTech is decisively pivoting beyond its pandemic-era identity, placing a substantial strategic bet on mRNA oncology....

The story of Healwell AI's stock is one of stark contrasts. While the company's latest financial reports reveal explosive revenue...

Shares of Viking Therapeutics gained approximately 2.9% to $36.42 following a pivotal regulatory decision that is reshaping the market for...

The investment case for Hims & Hers Health is currently defined by a stark tug-of-war. On one side, a bold...

Semler Scientific stands at a strategic crossroads, poised for a fundamental transformation. The medical diagnostics firm is charting a course...

Shares of medical device leader Abbott Laboratories opened the week on stable footing following a significant regulatory achievement. The company...

The telehealth provider Hims & Hers Health is accelerating its international strategy with a decisive move into Canada. This expansion...

Intellia Therapeutics finds itself in a challenging phase as regulatory delays for a key drug candidate trigger a wave of...

The past year has presented UnitedHealth with its most severe market challenges since the 2008 financial crisis. The healthcare behemoth,...